The Liberia Medicines and Health Products Regulatory Authority (LMHRA) has ordered the immediate recall of the analgesic Kaka Forte after the product tested positive for amphetamine during a Rapid Presumptive Colorimetric Test.
Kaka Forte, manufactured by AquaLab Pharmaceuticals in India, is registered as containing only Paracetamol 500mg and Caffeine 30mg (Anhydrous). The detection of amphetamine—an unapproved and controlled substance—represents a serious breach of pharmaceutical safety standards and regulatory compliance.
The LMHRA says the product will remain withdrawn from circulation pending the outcome of a third‑party confirmatory analysis.
Regulators warn that the presence of amphetamine in an over‑the‑counter formulation poses significant health risks. Potential adverse effects include increased heart rate and blood pressure, heightened anxiety or agitation, dependency risks, and other serious medical complications.
The LMHRA is urging consumers to immediately discontinue the use of Kaka Forte. Individuals who have taken the product and are experiencing unusual symptoms are advised to seek prompt medical evaluation.
Healthcare providers are further encouraged to report any suspected adverse reactions linked to the drug to the LMHRA or relevant local health authorities.
In addition, the Authority has instructed all importers, distributors, and retailers to remove Kaka Forte from their shelves without delay and suspend all sales until further notice. Sellers are also required to notify customers who may have purchased the product and advise them to stop using it.
